Hulogix
  • Main
  • Discover
  • Leadership Team
  • In Production
  • Patents
  • Newsroom
  • Clinical Trials
  • Contact
  • Twitter Feed
  • Under Construction

Obesity In Canines


12 Month Clinical study introducing anti-obesity compound  A15305 daily into the diet of obese canines under the age of 8 years meeting the inclusion criteria.  Medications will be taken for 3 months given in canine daily food intake.  Compound 15305 to increase weight loss, lower cholesterol, triglycerides.  Assist in the reduction of pulmonary & cardiac risks factors, aiding in reducing arthritis symptoms in obese canines.
Picture
 Inclusion Criteria:

Obese canines per Body Condition Scoring (4-5)
Male or Female <8 years of age
Spay and/or Neutered
May be positive for Thyroid Dx controlled on Medications
May be positive for Cushions Dx controlled on Medications

May be positive for CHF controlled
Current and up to date on vaccinations
Currently on Flea, Tick and Heart-worm Prevention

Picture
Exclusion Criteria:
​
Canines who are pregnant or currently feeding puppies
Diagnosed or history of Auto Immune Disease
Diagnosed or history of Cancer
Currently taking medications for allergies (must be off for 1 year)
Currently taking steroids (must be off for 1 year)
Currently taking Nsaids
Canine's with serious concurrent health issues
Abnormal blood results (Critical labs)

Does your dog meet this criteria,
​contact HuLogix @ inquiries@HuLogix.com for further evaluation

 Disclaimer: 

The contents of this web site, such as graphics, clinical information, tweets, and/or documents is for informational purposes only and does not replace professional treatment.   There is nothing on this web site to constitute medical advice for human or companion animals.  This website is not intended as a treatment for any medical diagnoses.    If you or your companion animal has a medical condition please consult a licensed physician and/or veterinarian.  Always consult with the appropriate professional for specific advice related to any medical condition.  Note; that while every attempt was made to insure all information within is accurate, errors or omissions may be contained therein, for which any liability is disclaimed. ​

Contact Us

    Subscribe Today!

Submit
  • Main
  • Discover
  • Leadership Team
  • In Production
  • Patents
  • Newsroom
  • Clinical Trials
  • Contact
  • Twitter Feed
  • Under Construction